Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27004,123,2.70 [1.91-3.82],1.9120600575221872e-08
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27764,208,1.82 [1.38-2.40],1.957750046305475e-05
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27480,1364,2.02 [1.81-2.25],3.3148120254795043e-37
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,27793,481,2.07 [1.73-2.47],1.7485413616920977e-15
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26924,3555,1.69 [1.57-1.81],1.7606527685576251e-47
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27156,2926,1.98 [1.83-2.14],9.727506065097407e-69
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27494,1393,1.80 [1.61-2.00],1.5588906312997527e-25
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27682,92,2.90 [2.01-4.17],1.0581133979139246e-08
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25899,832,2.81 [2.46-3.21],2.2516656977838364e-51
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25045,973,3.16 [2.80-3.56],1.165760204820512e-78
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25071,265,3.94 [3.15-4.94],1.0393759004771784e-32
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19516,1703,2.19 [1.98-2.41],4.209574039814519e-56
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24841,381,4.01 [3.33-4.82],3.2377965938819967e-49
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27727,1626,1.74 [1.58-1.93],8.387724345324563e-27
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Mycoses,27859,547,2.01 [1.70-2.38],3.531521891504067e-16
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27087,971,2.24 [1.98-2.54],7.148184572896241e-37
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27798,917,2.52 [2.22-2.86],4.667756568591781e-47
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26309,208,1.92 [1.45-2.54],5.133041449359489e-06
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27920,46,3.05 [1.78-5.22],4.5693841413190497e-05
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27685,804,2.61 [2.28-2.98],5.508270669992829e-45
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27674,84,1.21 [0.76-1.93],0.4269373614594088
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27820,193,1.77 [1.33-2.37],0.0001120845502946
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27802,175,1.54 [1.12-2.11],0.0072581705309673
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26468,352,2.55 [2.07-3.13],4.521135296001537e-19
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26385,269,2.09 [1.63-2.68],8.280507863756092e-09
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26233,132,2.66 [1.93-3.66],2.4073258809232395e-09
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27895,35,2.30 [1.21-4.36],0.0108052991925737
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27845,159,2.12 [1.56-2.88],1.800402350454323e-06
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral warts,27733,47,1.69 [0.93-3.08],0.0850516428974429
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27764,78,2.44 [1.59-3.73],3.925058705471498e-05
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign lipomatous neoplasm,27645,243,0.87 [0.65-1.16],0.3451686085927907
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27816,70,1.38 [0.83-2.29],0.2172225919010685
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27810,69,0.68 [0.39-1.19],0.1775034691192897
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27628,1252,1.08 [0.96-1.23],0.2065901514476238
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of meninges,27891,82,2.01 [1.30-3.10],0.001682280709569
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27852,66,1.43 [0.86-2.41],0.1711046140059827
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27886,136,1.20 [0.83-1.73],0.335057822765452
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of ovary,27834,180,1.01 [0.73-1.40],0.953846351506642
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27899,281,1.08 [0.83-1.40],0.5753449875372971
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Caecum,27906,253,0.94 [0.71-1.25],0.6874034579635185
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27830,65,0.94 [0.55-1.62],0.826079951631599
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,27901,160,1.28 [0.91-1.80],0.1493391978261713
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Rectum,27862,289,1.26 [0.98-1.62],0.0725298040608181
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27812,509,1.03 [0.85-1.25],0.7567207245783968
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27899,305,1.01 [0.79-1.30],0.936437151943428
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Carcinoma in situ of breast,22637,137,1.08 [0.73-1.58],0.701605902123695
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22730,167,0.79 [0.56-1.14],0.2058212605586689
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22707,32,2.23 [1.13-4.42],0.0211997177103037
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22744,69,1.29 [0.77-2.16],0.3310533918293603
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27851,138,1.12 [0.77-1.63],0.5572617350754023
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Haemangioma, any site",27852,136,1.10 [0.75-1.60],0.6371625970318281
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Leiomyoma of uterus,26912,594,1.01 [0.84-1.21],0.9515671270914547
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Lung cancer and mesothelioma,20040,316,1.24 [0.96-1.61],0.106299979902587
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Lymphoid leukaemia,22712,37,1.98 [1.03-3.80],0.03990700654827
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22855,180,1.04 [0.75-1.46],0.8016441062994022
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22789,114,1.20 [0.80-1.80],0.3855612497149269
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22863,188,1.14 [0.83-1.58],0.4078525549246629
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22746,71,1.05 [0.62-1.78],0.8575435772067797
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22748,73,1.83 [1.13-2.94],0.0131435672668136
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22732,57,1.21 [0.68-2.16],0.5113197719405281
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22819,144,1.04 [0.72-1.51],0.8195781462107449
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22778,103,1.01 [0.65-1.56],0.9812878256161596
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22762,87,0.87 [0.53-1.42],0.5753541195409682
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22717,42,1.36 [0.69-2.65],0.3742537616298643
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22758,83,1.21 [0.74-1.96],0.4530276321516705
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Melanocytic naevi,27656,235,1.07 [0.80-1.43],0.6394338930149199
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Melanocytic naevi of trunk,27873,82,0.89 [0.54-1.47],0.6494884743517336
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Melanoma in situ,22710,90,1.24 [0.78-1.97],0.3610392848458487
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22758,83,1.45 [0.91-2.30],0.1177535671612441
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22829,154,1.89 [1.36-2.61],0.0001288185805674
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22907,232,0.85 [0.63-1.15],0.2892272086597636
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22770,95,2.82 [1.94-4.10],5.2798981759873613e-08
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Other benign neoplasms of skin,27692,170,1.34 [0.97-1.86],0.0793533937741804
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23628,953,1.28 [1.12-1.48],0.000442350448172
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23669,994,1.28 [1.11-1.46],0.0004562440157632
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27608,377,1.80 [1.46-2.22],2.7905686767484504e-08
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25863,108,6.67 [5.11-8.71],1.934566405925249e-44
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27300,69,3.37 [2.24-5.07],6.02237399353085e-09
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26882,3025,1.80 [1.67-1.95],2.8418947802317544e-51
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26244,35,3.19 [1.71-5.96],0.0002731007101682
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27507,49,4.14 [2.64-6.49],6.55687584225687e-10
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27322,1567,1.99 [1.80-2.20],1.062317404239776e-39
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27322,1567,1.99 [1.80-2.20],1.062317404239776e-39
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25826,71,3.83 [2.54-5.79],1.8274692954978856e-10
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27501,1292,1.80 [1.61-2.02],3.2841213636032382e-24
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27582,124,2.59 [1.85-3.62],2.4980215110235665e-08
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27284,53,2.51 [1.50-4.18],0.0004206297836734
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27289,58,1.25 [0.71-2.19],0.4366025256278538
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27699,241,2.55 [2.01-3.24],1.8265230017031776e-14
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27806,62,3.98 [2.62-6.02],7.473022798468637e-11
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27661,203,2.71 [2.10-3.51],1.9472478728819683e-14
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26346,137,2.01 [1.43-2.83],6.552059820542795e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,22474,259,4.05 [3.26-5.03],1.2278715597955182e-36
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26473,68,0.87 [0.50-1.53],0.6291723291644753
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26470,65,1.13 [0.65-1.97],0.6596011952526804
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,22266,51,1.50 [0.81-2.79],0.19476352663069
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25609,72,2.13 [1.35-3.36],0.0011320386420073
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25235,251,1.63 [1.25-2.12],0.0002987105939741
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27474,521,2.00 [1.68-2.38],7.573036900219966e-15
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27242,289,1.26 [0.98-1.62],0.0737364685634186
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27040,87,0.92 [0.57-1.47],0.7186239450420413
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27511,1974,1.33 [1.21-1.46],8.574359749902281e-09
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24705,1922,1.34 [1.21-1.48],9.448238316439392e-09
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",22274,59,1.91 [1.10-3.34],0.0223578922859118
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24763,121,1.49 [1.02-2.19],0.0408715346055111
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,22502,287,2.84 [2.26-3.57],4.0343491784849296e-19
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,22263,48,0.82 [0.41-1.60],0.5540309242318744
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25416,3201,1.26 [1.17-1.37],3.950395489738627e-09
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,22421,206,2.70 [2.04-3.56],2.307060715910968e-12
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22759,544,2.27 [1.90-2.70],3.0913700618362124e-20
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27814,373,2.03 [1.65-2.49],2.2262630360440816e-11
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27624,183,2.58 [1.95-3.41],2.690567523219298e-11
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,22317,102,1.65 [1.07-2.53],0.0228392935117802
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",22272,57,4.20 [2.66-6.65],7.975752722540992e-10
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27009,2367,1.45 [1.33-1.58],4.219248852769254e-17
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,22425,210,5.46 [4.33-6.89],1.194485134660447e-46
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,22427,212,6.12 [4.95-7.58],2.272178930048633e-62
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22760,545,1.62 [1.34-1.95],3.322910875301333e-07
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,22310,95,2.33 [1.53-3.56],8.806745227970809e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27614,173,2.43 [1.82-3.25],2.235558931544979e-09
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22852,637,1.93 [1.64-2.28],4.242219142840464e-15
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22786,571,2.15 [1.81-2.55],2.6539949016860465e-18
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25056,72,2.22 [1.39-3.55],0.0008604599097213
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26991,4776,1.42 [1.33-1.51],2.5874488328103927e-28
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24719,77,1.51 [0.94-2.42],0.0916605360070148
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24731,89,1.21 [0.76-1.93],0.4301715843361501
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27716,2120,1.22 [1.11-1.34],4.663350660317777e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27721,2119,1.22 [1.11-1.34],3.598244133377228e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24724,82,2.09 [1.36-3.21],0.0008408553097977
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27501,1607,1.09 [0.97-1.21],0.1352617164091978
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23758,1543,2.25 [2.04-2.49],1.9234397945943696e-56
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27905,189,2.96 [2.28-3.85],4.628018148581542e-16
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27012,59,1.86 [1.10-3.14],0.0205224895496364
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26026,132,1.51 [1.05-2.17],0.0257104703332772
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26095,201,1.00 [0.73-1.37],0.9877935131512012
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",22485,270,1.70 [1.31-2.21],6.852007788450732e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26049,144,1.81 [1.30-2.53],0.0005097025735169
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1744,50,2.04 [1.21-3.45],0.0076311205238041
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1859,189,1.73 [1.32-2.28],7.759084568395252e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25932,27,5.03 [2.59-9.75],1.7613433090614383e-06
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1726,33,4.37 [2.48-7.70],3.176435030119317e-07
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27421,1516,1.46 [1.31-1.63],4.819883353412242e-12
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27295,342,1.72 [1.38-2.15],1.311419640789674e-06
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25478,494,1.80 [1.50-2.17],4.3684297345238646e-10
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22962,747,2.54 [2.20-2.93],1.0595141285004374e-37
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27816,234,1.66 [1.28-2.17],0.0001690197123487
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26889,55,2.34 [1.37-4.01],0.0018352582464443
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Angina pectoris,26351,889,1.53 [1.33-1.76],2.3743551219967162e-09
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26932,98,2.43 [1.64-3.62],1.087088441420328e-05
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26870,36,3.50 [1.94-6.31],3.193645483175076e-05
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26989,155,2.62 [1.93-3.56],8.130937165365778e-10
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18146,1506,1.80 [1.61-2.00],2.847109253007288e-26
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,AV-block,24441,243,1.67 [1.27-2.19],0.0002483329029524
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27876,310,1.17 [0.92-1.50],0.2024637113131081
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,16769,129,3.92 [2.85-5.41],7.478760472587206e-17
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24335,137,1.88 [1.31-2.69],0.0005570742018956
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",24279,81,2.75 [1.78-4.25],4.964802151663762e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27915,34,1.28 [0.61-2.68],0.5221107777970633
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Conduction disorders,24939,741,1.70 [1.46-1.99],1.5740860686318893e-11
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26983,1533,1.64 [1.48-1.83],1.851866067518602e-20
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25091,7385,1.27 [1.20-1.33],1.827476214717913e-18
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26375,249,1.63 [1.26-2.11],0.0002374463247262
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Endocarditis,24261,63,3.22 [2.00-5.17],1.3582546749631966e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27820,877,2.47 [2.17-2.81],7.934399777332462e-43
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypertension,25730,6248,1.28 [1.21-1.35],4.6586033806348466e-17
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25742,6260,1.29 [1.21-1.36],3.3291857961301282e-18
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27804,43,5.16 [3.34-7.98],1.52950406087308e-13
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19647,165,3.05 [2.31-4.03],4.03523115045162e-15
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19586,104,6.75 [5.37-8.50],9.839514830760521e-60
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypotension,27777,1128,1.88 [1.67-2.12],7.76847893456711e-25
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27147,99,1.05 [0.68-1.64],0.8117872294026052
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27182,1720,1.56 [1.41-1.73],3.314134260117848e-18
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27600,468,1.76 [1.46-2.12],2.7422923169142723e-09
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,24502,304,1.71 [1.34-2.18],1.570979716414222e-05
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27690,615,1.69 [1.43-1.98],3.8224005991989596e-10
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25955,493,1.98 [1.65-2.37],1.3087255190291452e-13
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27894,90,1.35 [0.86-2.10],0.1896976616266273
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27913,246,1.82 [1.41-2.36],5.023882955917232e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,26163,37,2.50 [1.34-4.67],0.0040585891961651
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other aneurysm,26893,59,1.29 [0.73-2.28],0.377658817686089
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,24561,363,1.94 [1.56-2.41],2.978446020434245e-09
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26903,69,3.52 [2.30-5.37],5.902009317602301e-09
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27033,199,2.70 [2.07-3.51],1.644746655035575e-13
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,24359,161,1.96 [1.41-2.73],6.301910971721155e-05
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,26222,96,1.94 [1.29-2.92],0.0013900638815063
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26172,46,1.38 [0.73-2.61],0.3147593859323677
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26636,41,1.08 [0.55-2.15],0.8162389307572041
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26293,167,1.46 [1.05-2.02],0.0237989325735144
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25021,823,2.05 [1.78-2.36],4.620431632874445e-23
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26693,44,3.15 [1.82-5.44],3.8161457189787537e-05
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27345,511,2.19 [1.84-2.60],4.650748021513879e-19
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27332,327,2.79 [2.29-3.40],3.319121235755513e-24
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27154,559,1.73 [1.46-2.06],4.054159914482633e-10
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16937,297,2.00 [1.56-2.58],5.994205924390565e-08
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27101,281,2.88 [2.32-3.59],3.209985058492476e-21
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26457,331,1.44 [1.14-1.81],0.0021547479564976
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27459,454,1.65 [1.36-2.00],4.553812987883554e-07
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27839,603,2.12 [1.81-2.48],1.9654776374592398e-20
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,24424,226,1.90 [1.44-2.50],6.050996875877023e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27323,318,2.80 [2.29-3.42],9.069383000077437e-24
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26760,165,2.73 [2.05-3.63],6.232028081641729e-12
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27593,545,1.58 [1.32-1.88],4.253431628482582e-07
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27567,593,1.56 [1.32-1.85],2.205710756444441e-07
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27112,72,1.11 [0.66-1.86],0.6946515064192758
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26881,47,1.98 [1.09-3.58],0.024448171621851
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27352,220,1.22 [0.92-1.63],0.1719826799379957
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27281,206,1.52 [1.14-2.02],0.0043987358041895
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Varicose veins,26592,466,1.60 [1.32-1.94],1.3136257901831897e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26846,98,1.90 [1.25-2.87],0.0024047065216221
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27700,716,1.55 [1.33-1.81],2.5443811720647643e-08
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27872,221,1.14 [0.85-1.53],0.376651955006688
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24797,1878,1.14 [1.03-1.26],0.0127910540182639
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,Any mental disorder,27295,4376,1.27 [1.19-1.35],1.4745110063735358e-12
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27840,262,1.17 [0.89-1.53],0.2523623908446908
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24915,1996,1.36 [1.24-1.50],4.152922237192788e-10
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23013,94,1.55 [1.01-2.41],0.0473544543534227
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,Smoking dependency,27496,1209,1.41 [1.25-1.59],2.90626681806118e-08
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24314,1395,1.42 [1.27-1.59],1.1466212950202095e-09
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,Vascular dementia,27410,105,1.91 [1.30-2.83],0.0011077288218801
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Alzheimer disease,27919,360,1.21 [0.97-1.52],0.0920399563917025
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",19063,58,1.92 [1.09-3.40],0.0248981019454255
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Bell's palsy,25730,87,1.97 [1.28-3.03],0.0018990275015375
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26287,644,1.16 [0.98-1.38],0.086764617908692
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Cerebral cysts,27505,225,1.56 [1.18-2.06],0.0016706860409826
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27844,284,1.90 [1.51-2.40],7.101154562997766e-08
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27426,39,0.87 [0.43-1.78],0.709613099008841
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27905,48,2.53 [1.48-4.32],0.0006594087505721
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27337,57,1.94 [1.15-3.28],0.0132585265976688
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Epilepsy,26404,290,1.58 [1.23-2.01],0.0002621704535839
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27492,1378,1.31 [1.16-1.47],6.486802233998982e-06
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27870,522,1.27 [1.06-1.53],0.0110258462030932
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27267,2954,1.37 [1.27-1.48],1.4865039335827373e-15
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,27538,48,0.82 [0.43-1.57],0.5485283655901148
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Hemiplegia,27786,226,2.45 [1.92-3.14],9.558061250758473e-13
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Hydrocephalus,27348,68,0.95 [0.55-1.63],0.8586959377578705
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27899,78,1.90 [1.21-2.98],0.0051690366267347
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25769,126,0.98 [0.66-1.47],0.9339658918645136
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25711,68,1.48 [0.89-2.47],0.1326190221300859
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Memory loss,27281,101,1.21 [0.79-1.85],0.3929523843614221
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Migraine,26636,522,1.19 [0.98-1.45],0.0719298970835755
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27803,469,1.15 [0.94-1.41],0.1697454589348541
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Motor neuron disease,19155,123,0.69 [0.45-1.05],0.0858973577447732
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27696,147,0.86 [0.59-1.25],0.4323134636744781
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27056,1413,1.24 [1.11-1.39],0.0002313085895464
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Neurological diseases,26273,3860,1.23 [1.15-1.32],6.573654565206389e-09
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27550,163,2.19 [1.63-2.95],2.615438992774716e-07
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26076,433,1.17 [0.94-1.44],0.1540329869032257
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27860,236,1.96 [1.52-2.53],2.829688106089037e-07
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22490,675,1.34 [1.13-1.59],0.0005919565551794
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27348,68,1.26 [0.75-2.13],0.3772805149617914
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27405,125,1.85 [1.30-2.65],0.0006761510948782
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27535,187,1.69 [1.26-2.28],0.0005265763736958
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25740,97,1.85 [1.23-2.79],0.0033616087106869
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other headache syndromes,26189,75,1.08 [0.65-1.81],0.7565019093090559
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other neurological diseases,27795,515,1.46 [1.21-1.76],6.093872580784418e-05
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other sleep disorders,26529,415,1.44 [1.17-1.78],0.000584238967569
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Parkinson's disease,27894,318,1.07 [0.84-1.36],0.5851862480939659
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27363,83,1.15 [0.71-1.88],0.5619514396767684
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,27918,105,1.41 [0.94-2.13],0.0985208291742866
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Sleep apnoea,27736,328,1.52 [1.21-1.91],0.0003960639420829
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27664,40,3.32 [1.97-5.59],6.11592800715726e-06
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27909,153,0.68 [0.47-0.99],0.0438939965074948
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25709,66,1.40 [0.83-2.35],0.202579259817862
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27919,364,1.23 [0.98-1.53],0.0692611730225813
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27366,102,2.07 [1.40-3.06],0.0002493458434638
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27324,112,1.03 [0.68-1.55],0.8948390404960604
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27446,493,1.06 [0.87-1.29],0.566675835733877
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27771,177,1.91 [1.42-2.59],2.242443930661128e-05
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26792,64,0.88 [0.50-1.54],0.6533893015595174
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26782,54,0.85 [0.46-1.59],0.6212006066988347
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27795,60,1.62 [0.96-2.74],0.073001086182116
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27630,170,1.21 [0.87-1.69],0.2532395720932897
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1733,39,4.15 [2.52-6.83],2.2100722814155964e-08
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2083,73,2.02 [1.36-3.02],0.000559658497165
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27306,94,0.85 [0.53-1.36],0.4948709349447517
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27737,1080,1.18 [1.03-1.34],0.0156457005039321
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27494,766,1.12 [0.96-1.31],0.1561440557045711
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27028,300,1.22 [0.95-1.56],0.1220960087094276
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27826,873,0.98 [0.85-1.14],0.8402933044536943
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27902,71,1.62 [1.00-2.62],0.050561186904759
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27745,792,0.98 [0.83-1.14],0.7580995185591687
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27870,410,1.27 [1.03-1.57],0.0277688650721419
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27822,210,1.08 [0.80-1.46],0.6201367283500133
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26769,41,2.08 [1.15-3.76],0.0151133101827688
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26774,46,1.20 [0.63-2.26],0.5823286780002702
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26794,66,1.09 [0.64-1.86],0.7387944728601964
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27828,740,0.86 [0.73-1.01],0.0744753808920416
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27275,187,0.86 [0.62-1.20],0.3817835336224386
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27020,67,0.58 [0.33-1.01],0.0548136667946301
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27562,102,1.34 [0.88-2.03],0.171519219837698
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27777,317,1.28 [1.00-1.62],0.0456846024539369
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27169,216,0.87 [0.64-1.18],0.3793359354391211
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27749,137,1.05 [0.72-1.53],0.7912959294753574
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27573,485,1.01 [0.83-1.23],0.9043624616311584
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27365,153,1.25 [0.88-1.77],0.2049153795106843
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26087,2546,1.16 [1.06-1.26],0.0008957078553866
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27736,276,1.25 [0.97-1.62],0.0868365799961985
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27893,159,1.67 [1.21-2.31],0.00179106201146
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27127,399,1.05 [0.85-1.31],0.6402361808729883
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27523,63,1.14 [0.66-1.96],0.6442849655096128
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27887,56,1.47 [0.85-2.55],0.1722690980224838
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26822,94,1.20 [0.77-1.87],0.4222152891713145
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26884,156,1.04 [0.73-1.48],0.8309232185304695
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26766,109,1.62 [1.10-2.40],0.0152707403521138
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27026,73,1.17 [0.71-1.95],0.539213200014284
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26719,62,0.45 [0.25-0.82],0.0093517345998526
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27211,123,0.61 [0.40-0.92],0.0185450436866227
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27271,183,0.94 [0.68-1.30],0.7134330791846432
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26865,137,1.05 [0.72-1.52],0.8139698420433404
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26757,100,0.99 [0.63-1.56],0.972401563786987
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26734,77,1.24 [0.76-2.03],0.3795820964364617
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25681,2140,1.09 [0.99-1.20],0.0666993263968197
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26813,85,1.26 [0.79-2.00],0.3320985933836555
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27650,438,1.08 [0.88-1.33],0.4784997394093941
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27261,49,1.22 [0.66-2.24],0.5203782885953165
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27383,171,1.41 [1.02-1.94],0.0376681181696944
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27672,117,1.15 [0.77-1.71],0.5073090506350142
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27871,117,1.26 [0.85-1.88],0.2467049722914444
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27789,145,1.26 [0.88-1.81],0.1997173770591981
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27624,69,1.42 [0.86-2.35],0.1686318701665024
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27628,73,2.16 [1.37-3.39],0.0008578702432919
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27816,833,1.42 [1.23-1.64],2.218177374758995e-06
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27553,570,1.47 [1.23-1.75],1.8483297322120248e-05
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27108,125,1.52 [1.05-2.20],0.0269456600120462
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27071,88,0.86 [0.53-1.38],0.5232137039552789
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,27645,88,1.94 [1.27-2.97],0.0021802929421552
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27792,235,1.58 [1.20-2.07],0.0009724048520047
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27622,65,2.21 [1.37-3.57],0.0012335800806798
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,All influenza,26168,128,3.65 [2.67-5.00],6.81164539366263e-16
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26166,126,3.45 [2.50-4.76],5.230562441799057e-14
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19848,124,1.00 [0.66-1.51],0.9921908752586138
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,27761,291,0.98 [0.75-1.27],0.8739328889378258
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21617,2085,1.26 [1.14-1.39],5.715205018289556e-06
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21782,2058,1.24 [1.13-1.37],1.600545785682945e-05
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27494,126,2.44 [1.75-3.40],1.486292708269575e-07
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26107,67,2.98 [1.88-4.71],2.9499261142985126e-06
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Bronchiectasis,24162,417,2.17 [1.79-2.62],2.158981825880115e-15
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23818,73,1.58 [0.97-2.59],0.067838750435211
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26741,2996,1.29 [1.19-1.40],1.9412591388387523e-10
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26616,62,1.21 [0.70-2.09],0.5047642201290607
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26700,146,0.88 [0.61-1.29],0.5193185488260597
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27741,1072,1.71 [1.51-1.94],3.1238279410229146e-17
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26629,75,0.66 [0.39-1.13],0.1310048610654658
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25793,5236,1.42 [1.33-1.50],5.334338840639318e-30
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26890,336,0.97 [0.76-1.24],0.8256423649556288
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Early onset COPD,26991,322,2.04 [1.64-2.54],2.0649329419298827e-10
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Emphysema,24024,279,2.30 [1.83-2.90],1.1395283267339325e-12
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26251,233,2.87 [2.26-3.63],2.895469817632724e-18
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27716,1676,2.20 [2.00-2.42],1.0743869850042193e-58
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26292,274,2.97 [2.39-3.68],8.874454966213452e-23
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Later onset COPD,26982,750,1.58 [1.36-1.84],2.962788585474711e-09
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27911,230,2.13 [1.65-2.75],5.099554016731621e-09
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Nasal polyp,26625,71,0.86 [0.50-1.47],0.581836519520614
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27696,940,1.93 [1.69-2.20],3.428235418211027e-23
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,27728,1788,1.88 [1.71-2.07],1.973724456046229e-38
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27350,796,0.98 [0.84-1.15],0.8082876057942445
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other pleural conditions,25977,37,1.58 [0.78-3.20],0.2073638197934041
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27837,351,2.80 [2.32-3.39],1.921517628057486e-26
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27831,1205,1.97 [1.76-2.21],3.2444784639977493e-31
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pleural effusion,26805,865,1.96 [1.71-2.25],8.962179789694247e-22
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pleural plaque,25986,46,1.53 [0.82-2.88],0.1838784336075126
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27480,1440,2.21 [2.00-2.45],1.2019017815679504e-51
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27881,200,2.28 [1.74-2.98],1.7160125074788502e-09
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pneumothorax,26033,93,1.20 [0.76-1.90],0.4360193266531619
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pollen allergy,27886,243,0.94 [0.70-1.26],0.6746293719052028
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,27550,64,3.41 [2.24-5.18],9.686143128774838e-09
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19777,53,3.41 [1.99-5.87],8.739085588429021e-06
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27670,914,1.96 [1.72-2.24],7.225201041921958e-24
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26845,291,0.98 [0.75-1.27],0.8737063879453941
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Viral pneumonia,26257,217,2.52 [1.92-3.29],1.858086172614123e-11
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27505,173,2.39 [1.78-3.21],8.166475871422016e-09
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13490,107,1.08 [0.69-1.70],0.7419876674856682
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19917,38,2.80 [1.49-5.27],0.0013713565120836
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute appendicitis,27730,147,1.20 [0.84-1.73],0.3207228125400735
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute gastritis,20952,93,2.20 [1.46-3.30],0.0001454837105431
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,25576,166,1.50 [1.09-2.08],0.0135186002003768
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute peritonitis,27330,89,3.07 [2.11-4.46],4.14130438617807e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27023,34,2.17 [1.09-4.32],0.0269728757345368
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,21201,342,1.40 [1.11-1.77],0.0045730604426459
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25489,79,2.20 [1.43-3.38],0.0003493408714894
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27477,79,2.15 [1.40-3.31],0.0005158963455717
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Cholecystitis,25598,188,1.50 [1.11-2.04],0.0083804648367657
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Cholelithiasis,26616,1206,1.47 [1.30-1.66],5.125789241086016e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Chronic gastritis,21205,346,1.55 [1.24-1.95],0.0001560783860883
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25452,42,1.86 [1.00-3.45],0.0485785107997071
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27835,74,3.05 [2.02-4.61],1.3081803573789997e-07
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Coeliac disease,26327,156,2.16 [1.58-2.96],1.766033333060561e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Collagenous colitis,25982,113,1.40 [0.93-2.10],0.1032816378166257
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27781,153,1.26 [0.89-1.79],0.1948337904652268
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Constipation,27567,1757,1.41 [1.27-1.56],2.597635418761868e-11
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Crohn disease,25964,95,2.98 [2.08-4.29],3.5810386566967404e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27548,71,2.80 [1.84-4.25],1.6067248203592672e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25968,99,2.92 [2.05-4.18],4.1156458357595934e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Dental caries,27076,234,1.81 [1.39-2.36],1.2584526734442537e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26267,2511,1.29 [1.18-1.41],5.703887736545584e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of appendix,27773,190,1.15 [0.84-1.59],0.3808689887104725
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of liver,27813,824,1.81 [1.57-2.08],2.6561351999775653e-16
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25579,4720,1.22 [1.15-1.30],4.0709005003519287e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27439,597,1.37 [1.15-1.63],0.0004835258983657
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27793,552,1.61 [1.35-1.93],1.0919613437413725e-07
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26962,120,1.41 [0.96-2.08],0.0792401312460369
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26807,64,1.36 [0.80-2.32],0.2618415514685143
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27612,1441,1.46 [1.30-1.63],3.4043578712970794e-11
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of tongue,26818,113,1.11 [0.73-1.68],0.6258088768797556
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27026,1616,1.46 [1.31-1.62],1.324416230820659e-12
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23132,3253,1.19 [1.11-1.29],6.206823279383722e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,20990,131,1.87 [1.31-2.68],0.0005973785241321
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27867,111,1.60 [1.08-2.35],0.0180205385659144
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27814,65,1.98 [1.20-3.27],0.0075245590904915
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27083,94,3.11 [2.15-4.49],1.4552036262241851e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19993,114,1.40 [0.92-2.12],0.112685889474472
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,21533,674,1.09 [0.92-1.29],0.3420745706112346
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastric ulcer,21212,353,1.26 [1.00-1.58],0.0526252840649795
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23707,2848,1.26 [1.16-1.37],3.111593353425633e-08
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21338,479,1.42 [1.17-1.73],0.0004131947221717
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21836,8606,1.23 [1.18-1.30],1.4090768111730893e-17
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,GI-bleeding,27334,1163,1.43 [1.27-1.62],1.1680589054672445e-08
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26906,64,1.36 [0.80-2.32],0.257525950804831
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20869,1287,1.16 [1.02-1.31],0.0226104842208222
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27030,41,2.88 [1.62-5.11],0.000321334349198
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Hernia,26707,2951,1.31 [1.21-1.42],2.2279968583739892e-11
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Impacted teeth,27824,60,2.10 [1.26-3.52],0.0046865283378335
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Impaction of intestines,19944,65,2.21 [1.35-3.62],0.0015648787079653
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Inguinal hernia,23921,165,1.57 [1.14-2.17],0.0062149720272821
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19983,104,1.53 [1.00-2.33],0.0478736467229931
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26353,182,1.94 [1.44-2.62],1.4472363930867756e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20709,830,1.30 [1.11-1.52],0.0008355651505027
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27904,363,1.73 [1.39-2.14],6.208598197215722e-07
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26700,831,1.49 [1.29-1.72],9.438472748826849e-08
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26993,1124,1.49 [1.31-1.69],4.5593510385067534e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,21021,162,1.78 [1.28-2.47],0.0005710556883705
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Oesophagitis,21440,581,1.31 [1.09-1.57],0.0031971254419926
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27871,157,0.95 [0.66-1.35],0.7658246523008084
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23817,61,1.25 [0.72-2.18],0.4297762425259729
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,21177,1298,1.27 [1.12-1.43],0.0001385945878387
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25712,302,1.44 [1.13-1.83],0.0028748803118983
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,25602,192,1.11 [0.81-1.53],0.51130752350611
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,21495,1616,1.25 [1.12-1.39],7.190417278100579e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,25706,5827,1.25 [1.18-1.32],3.1972131402700987e-14
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26807,231,1.02 [0.76-1.37],0.8932650522684036
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of liver,27682,693,1.73 [1.48-2.03],4.1764713875492724e-12
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21445,586,1.37 [1.15-1.64],0.0004900061533984
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25570,160,1.96 [1.43-2.68],2.383040605954669e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27728,487,1.44 [1.19-1.75],0.0001814177843356
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21966,1107,1.51 [1.33-1.72],2.1090227961306046e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27353,1182,1.43 [1.27-1.62],9.319660682630178e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27038,196,1.09 [0.80-1.49],0.5931764576549061
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21692,1813,1.46 [1.32-1.62],8.153939322685187e-14
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23008,2149,1.29 [1.18-1.42],8.779977259405496e-08
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27090,101,2.96 [2.08-4.23],2.2056837320712744e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26857,988,1.45 [1.27-1.66],6.715104797913896e-08
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20218,339,1.63 [1.30-2.05],2.8228933392562848e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27803,75,1.74 [1.08-2.83],0.0239282809891233
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20384,505,1.59 [1.31-1.91],1.5928481204232226e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26306,135,1.56 [1.09-2.24],0.0162106227852617
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27910,70,1.67 [1.03-2.73],0.0391439281453006
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26843,128,1.38 [0.94-2.01],0.0997938444835359
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Toxic colitis,25936,67,1.64 [0.99-2.72],0.0561361689546282
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,21091,232,1.59 [1.21-2.09],0.0007795631448548
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,26042,173,1.87 [1.38-2.55],6.498983920057787e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26011,142,1.95 [1.40-2.73],9.576746162393888e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Umbilical hernia,23932,176,1.35 [0.97-1.86],0.0727267114994625
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,20072,193,1.97 [1.46-2.65],7.495008498219821e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Ventral hernia,24011,255,1.80 [1.39-2.32],6.683651226892669e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Volvulus,19967,88,1.15 [0.72-1.85],0.5587040999987735
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27832,265,1.20 [0.92-1.57],0.1724774124236943
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27591,77,2.38 [1.55-3.65],7.328420142398787e-05
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25807,226,0.91 [0.67-1.23],0.523837882629369
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27382,642,2.13 [1.83-2.49],4.2936187211650045e-22
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26888,148,1.62 [1.15-2.29],0.0059178990546122
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25923,342,2.74 [2.24-3.35],7.808634120323683e-23
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27595,285,1.75 [1.37-2.23],5.726437193354965e-06
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27804,494,2.01 [1.68-2.40],1.734531547266479e-14
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27362,52,3.05 [1.86-5.00],1.08001333789524e-05
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26286,3237,1.44 [1.34-1.56],1.0846592436781005e-21
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27460,492,1.14 [0.93-1.38],0.2036719425048344
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27306,338,1.01 [0.80-1.29],0.9051758882218977
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27597,857,2.00 [1.75-2.29],6.482534190756912e-24
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27896,78,1.32 [0.81-2.14],0.2591763311352766
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25673,92,4.22 [3.06-5.83],1.6193602394768393e-18
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27015,47,2.77 [1.65-4.64],0.0001136972373259
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27579,269,1.71 [1.33-2.20],2.417634346019972e-05
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26007,426,1.08 [0.87-1.34],0.5019978312762365
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,25629,48,1.64 [0.90-3.00],0.1080151271700771
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27811,87,1.90 [1.25-2.90],0.0027099781902355
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26897,157,2.56 [1.90-3.46],9.08668314868787e-10
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27683,169,1.68 [1.23-2.30],0.0011921474197641
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27369,59,3.02 [1.86-4.91],7.962462444436154e-06
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25648,67,1.04 [0.60-1.79],0.8924204849196411
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27214,1633,1.50 [1.36-1.67],1.2585447633256472e-14
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26044,463,1.11 [0.90-1.37],0.3156837540115433
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25634,53,1.70 [0.96-3.01],0.0681680209907149
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27830,316,1.70 [1.35-2.14],6.4564432767540215e-06
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27394,84,2.32 [1.54-3.51],6.124639528015005e-05
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27755,241,1.83 [1.41-2.37],4.91485379330079e-06
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27867,300,1.18 [0.92-1.51],0.2002492346786767
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25744,163,0.84 [0.59-1.21],0.358284341034944
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25848,267,0.94 [0.72-1.25],0.6856363248871279
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27853,286,1.18 [0.91-1.52],0.2116760076008129
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25788,207,3.50 [2.76-4.44],8.804841387557614e-25
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27883,159,1.45 [1.04-2.01],0.02896715570796
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23828,128,1.23 [0.83-1.82],0.3002148087853829
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25360,6510,1.19 [1.13-1.26],1.8824271017199408e-10
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23937,5087,1.20 [1.12-1.27],1.6845132809782068e-08
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23780,80,0.88 [0.52-1.47],0.6251628944065777
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23950,156,1.27 [0.90-1.80],0.1803894317276305
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24011,217,1.50 [1.13-2.00],0.0054139258492198
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27624,116,1.09 [0.72-1.64],0.6816474213839723
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23912,118,2.07 [1.44-2.99],9.549957869901997e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,20249,1399,1.19 [1.06-1.34],0.0042711436299264
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27763,228,1.18 [0.89-1.56],0.2609163618868977
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24414,620,1.17 [0.98-1.39],0.089404145456435
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,23470,8274,1.16 [1.11-1.22],2.4995679413842067e-09
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,25017,141,1.57 [1.10-2.24],0.01341520925851
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23834,134,1.86 [1.31-2.64],0.0005016373985274
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24398,698,0.92 [0.77-1.09],0.3347717534226476
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26885,3091,1.23 [1.13-1.33],3.489432838116433e-07
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23882,182,1.00 [0.72-1.39],0.993876745672351
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24086,386,1.61 [1.30-2.00],1.711513924171981e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23875,175,0.71 [0.50-1.01],0.0594132668028043
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26948,110,1.17 [0.77-1.79],0.45207267337607
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20767,1917,1.16 [1.05-1.29],0.0039178834077858
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19081,231,3.99 [3.17-5.03],8.785889861960282e-32
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27906,228,3.74 [2.98-4.70],1.0102991451928513e-29
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18952,102,0.48 [0.30-0.77],0.0025503378351988
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19430,580,1.16 [0.96-1.40],0.1166800758936101
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24038,338,0.86 [0.67-1.10],0.2285914915289026
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19498,648,0.90 [0.75-1.09],0.2812726339442421
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23862,68,2.13 [1.32-3.44],0.0018827622187253
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24523,729,1.38 [1.18-1.62],6.056589109093892e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24134,340,1.16 [0.91-1.47],0.2402596621272594
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19455,605,0.88 [0.73-1.07],0.2034285658411767
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23795,95,1.53 [0.99-2.36],0.0558215384074602
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23768,68,1.20 [0.70-2.04],0.5084026221917526
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24926,50,2.60 [1.50-4.48],0.0006164260142282
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27431,2555,1.35 [1.24-1.47],3.8036832236962e-12
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26709,1833,1.37 [1.24-1.51],8.848548457749246e-10
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27714,615,2.33 [2.00-2.73],1.00523791519496e-26
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21946,3096,1.31 [1.21-1.42],1.9524121389566763e-11
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18924,74,1.03 [0.60-1.77],0.9057051715612588
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23804,104,1.60 [1.06-2.42],0.0247969831768734
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18892,42,1.04 [0.52-2.08],0.9156848160601432
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),19053,203,1.26 [0.92-1.72],0.1481595295959181
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25173,297,1.18 [0.91-1.52],0.2155758514166793
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,25474,598,1.50 [1.26-1.79],6.170375409142415e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27889,117,1.72 [1.18-2.50],0.004832120196064
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25875,2081,1.23 [1.12-1.35],2.736100539915325e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23833,133,1.20 [0.82-1.76],0.3569415270418936
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),19087,237,1.53 [1.16-2.03],0.002795927260494
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24627,833,1.10 [0.94-1.29],0.2170607466458937
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,21445,2595,1.17 [1.08-1.28],0.0003326669861353
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26971,133,1.83 [1.28-2.61],0.0008760205606908
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27898,76,2.27 [1.47-3.51],0.0002331097731914
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23779,79,0.94 [0.57-1.56],0.8223009826160262
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25207,1507,1.51 [1.36-1.68],7.525647063863016e-14
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23784,84,1.67 [1.06-2.63],0.0260591007841022
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20877,2027,1.28 [1.16-1.41],8.182579183590817e-07
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,25014,138,0.91 [0.62-1.35],0.6509098649134342
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23764,64,0.76 [0.42-1.36],0.350190511591928
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,24000,206,0.91 [0.66-1.25],0.5532664647283432
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24301,601,1.88 [1.60-2.21],2.8616209987576e-14
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27354,516,2.19 [1.84-2.61],5.993966437321673e-19
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24457,663,1.43 [1.21-1.69],2.449787178299621e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27729,595,2.38 [2.03-2.78],3.3532318730254525e-27
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27891,70,3.19 [2.13-4.78],1.8695935046148165e-08
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23930,230,1.21 [0.90-1.62],0.1987993863134969
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21436,935,1.54 [1.34-1.77],1.3080130956950147e-09
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24386,686,1.44 [1.22-1.69],1.1443193408555722e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23827,127,1.12 [0.76-1.66],0.5612565957875058
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18927,77,1.11 [0.67-1.86],0.6775599963363699
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21543,2693,1.44 [1.33-1.57],3.637896843602203e-18
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19711,861,1.33 [1.14-1.54],0.0002044911928217
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27141,303,1.33 [1.04-1.70],0.0235652976171624
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27859,87,2.23 [1.48-3.35],0.0001324637799546
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",25573,55,1.44 [0.83-2.49],0.1960951045794926
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18927,77,2.52 [1.61-3.96],5.5307243221494334e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23909,115,1.19 [0.79-1.80],0.4090509876554166
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19470,620,2.45 [2.09-2.87],7.16901980010823e-29
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24035,335,0.91 [0.71-1.16],0.4458536080907261
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24083,289,1.44 [1.12-1.86],0.004479464939902
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,24078,284,1.16 [0.89-1.50],0.2751407562562193
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21560,87,1.31 [0.81-2.11],0.2666719294237733
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27898,77,3.15 [2.13-4.65],7.625741874333335e-09
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24349,649,0.95 [0.80-1.13],0.5720194244250951
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27002,164,4.23 [3.32-5.38],1.070111864461501e-31
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26573,2873,1.21 [1.12-1.31],4.0914612176278335e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23856,156,1.10 [0.77-1.56],0.615052999051078
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24374,580,1.33 [1.11-1.59],0.0019202297576959
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26158,273,1.09 [0.83-1.43],0.5228619064128717
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,24079,285,0.98 [0.75-1.27],0.8621896311523519
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25594,1800,1.23 [1.11-1.37],5.441386960979515e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25023,1229,1.22 [1.08-1.38],0.0015654863880162
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23766,66,1.61 [0.96-2.69],0.0715674387672455
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27068,230,3.95 [3.22-4.84],5.6811688254170795e-40
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23902,202,0.94 [0.69-1.30],0.7164898186033286
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23827,127,1.12 [0.76-1.66],0.5590897768246699
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18906,56,2.08 [1.20-3.58],0.0086473192673735
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26820,1278,3.79 [3.41-4.20],5.345644341741336e-140
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20897,103,1.15 [0.74-1.77],0.5368923123505946
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27206,113,1.23 [0.81-1.86],0.3329230110418525
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27753,238,1.59 [1.22-2.08],0.0006754566297089
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27541,26,2.48 [1.18-5.23],0.0167786563307811
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27057,1515,4.51 [4.13-4.93],3.005026225144069e-242
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27740,82,6.79 [5.31-8.69],2.386064690322725e-52
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27707,247,2.23 [1.74-2.86],2.8082366096562344e-10
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Cystitis,24630,255,1.51 [1.16-1.97],0.0022340820148557
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Dialysis,25594,52,14.64 [10.98-19.54],2.1652171932935626e-74
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27437,344,1.30 [1.03-1.64],0.0274834007421735
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20978,184,1.13 [0.81-1.57],0.4804851164307674
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21196,402,1.02 [0.81-1.28],0.8768244417207839
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21821,1027,1.06 [0.93-1.22],0.3964027287237494
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21733,5155,1.58 [1.48-1.68],3.4069924199980856e-49
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27724,66,6.40 [4.47-9.17],4.8448530829972055e-24
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,25419,215,1.42 [1.04-1.93],0.0256361364872575
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27358,405,1.05 [0.84-1.31],0.6444279417171855
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27444,131,0.65 [0.42-0.98],0.0403758679670703
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21102,308,1.26 [0.97-1.63],0.0819852962342686
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24453,78,2.10 [1.34-3.29],0.0011543926643165
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23294,2500,1.10 [1.00-1.20],0.0411556859965531
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20937,143,1.51 [1.06-2.16],0.02200710726896
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27904,65,1.34 [0.80-2.25],0.271537942237317
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27908,76,1.20 [0.74-1.95],0.4625129603538302
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26654,2279,1.58 [1.44-1.72],1.6909779153148e-24
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24854,479,1.17 [0.95-1.43],0.1364347675041189
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27212,119,1.29 [0.87-1.92],0.1990244218356632
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27856,396,2.69 [2.24-3.24],1.0613332020297295e-25
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27855,91,1.44 [0.93-2.23],0.0991031794200192
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26332,1957,1.71 [1.56-1.88],5.6454730297602594e-30
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27163,210,1.18 [0.87-1.60],0.2865806297416576
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20950,156,0.82 [0.57-1.18],0.2878799379252012
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21171,377,1.12 [0.89-1.40],0.3392290671571657
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20907,113,1.10 [0.73-1.67],0.6367024932316014
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21003,209,0.89 [0.65-1.21],0.4643294299883485
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25471,267,1.97 [1.51-2.57],5.053757254531548e-07
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27588,128,2.71 [1.96-3.77],2.4170577628686544e-09
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21107,313,1.07 [0.84-1.38],0.5731788304318639
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20903,109,1.09 [0.71-1.67],0.7042680784077529
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21453,659,1.02 [0.85-1.21],0.8578981369210612
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20955,161,1.30 [0.93-1.81],0.1234570482312482
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21391,597,1.03 [0.86-1.24],0.7108620509328681
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27695,37,2.99 [1.66-5.37],0.0002591466610722
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27718,2514,3.10 [2.87-3.35],1.204407810718918e-182
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",25371,167,3.39 [2.52-4.55],5.055073224089282e-16
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25646,104,6.62 [4.97-8.83],4.6931895420122843e-38
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27550,35,1.06 [0.50-2.24],0.8829652915205867
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24523,148,2.11 [1.53-2.91],5.186563338045081e-06
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27786,271,1.61 [1.25-2.07],0.0001914794264435
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20937,143,1.04 [0.71-1.51],0.8497991697949776
